Elisabet
Guruceaga Martínez
Bioinformática
Stanford University School of Medicine
Stanford, Estados UnidosPublicaciones en colaboración con investigadores/as de Stanford University School of Medicine (4)
2023
-
LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 29, Núm. 6, pp. 1137-1154
-
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer
Nature Communications, Vol. 14, Núm. 1
2020
-
The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas
Journal of Clinical Investigation, Vol. 130, Núm. 4, pp. 1879-1895
2017
-
An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer
Nature Communications, Vol. 8